Data show large decreases in atherosclerotic plaque following treatment with epeleuton Dublin, Ireland, 3rd June 2021 – Afimmune, a clinical stage drug discovery company focused on […]
Dublin, Ireland, 18th December 2018 – Afimmune, a privately held clinical stage drug discovery and development company, today announced receipt of allowance for a patent application in […]
